Tarsons Products has debuted at Rs 700.00 on the BSE, up by 38 points or 5.74% from its issue price of Rs 662.
The scrip is currently trading at Rs 825.15, up by 163.15 points or 24.65% from its issue price. It has touched a high and low of Rs 832.00 and Rs 634.00 respectively. So far 16.97 lakh shares were traded on the counter.
The offering, which was open for subscription between November 15, 2021 and November 17, 2021, was subscribed 77.49 times. The issue price was fixed at Rs 662 per share i.e. at upper end of price band of Rs 635- 662 apiece.
Tarsons Products is an Indian labware company engaged in the designing, development, manufacturing and marketing of ‘consumables’, ‘reusables’ and ‘others’ including benchtop equipment, used in various laboratories across research organizations, academia institutes, pharmaceutical companies, Contract Research Organizations (CROs), Diagnostic companies and hospitals.
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: